Related Experiment Video
Updated: Sep 2, 2025

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.3K
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer
Ganimete Lamaj1, Alberto Pablo-Trinidad1, Ian Butterworth1
1Leuko Labs, Inc, Boston, MA, United States.
Journal of Medical Internet Research
|August 9, 2022
Summary
A new noninvasive device, PointCheck, allows untrained users to screen for neutropenia at home. This technology offers a user-friendly and effective method for monitoring a critical side effect of chemotherapy.
Area of Science:
- Oncology
- Medical Devices
- Biotechnology
Background:
- Chemotherapy patients risk serious infections due to neutropenia, a low white blood cell count.
- Febrile neutropenia, a common and potentially fatal chemotherapy side effect, requires timely detection of severe neutropenia (<500 absolute neutrophil count/μL).
- Current blood draw methods for neutropenia monitoring are invasive and limited to clinical settings, hindering frequent or portable monitoring.
Purpose of the Study:
- To evaluate the usability of PointCheck, a noninvasive optical device for screening severe neutropenia.
- To identify user interface, functionality, and design issues from the perspective of untrained users.
Main Methods:
- A multicenter study involving 154 untrained participants evaluated PointCheck usability.
- A mixed-method approach included user testing observations, qualitative questionnaires, and the System Usability Scale (SUS) survey.
- Quantitative and qualitative data were collected to assess perceived usability and satisfaction.
Main Results:
- 108 out of 154 participants (70.1%) achieved SUS scores above 80.8, with a mean SUS score of 86.1.
- 145 out of 151 users (96%) reported learning to use PointCheck very quickly.
- 141 out of 151 users (93.4%) felt very confident using the device.
Conclusions:
- PointCheck is a novel, noninvasive technology for home-based neutropenia detection.
- First-time users can operate PointCheck safely and effectively in a simulated home environment.
- The device demonstrates excellent usability, ranking in the top tenth percentile for systems evaluated by the SUS.
Keywords:
cancerchemotherapydecision support systemsdiagnosisdigital healthinfectionmedical devicepatient-centered careremote monitoringtechnologyusabilitywhite blood cellwhite blood cells
